Screening compound: C25H35N5O2 (P636-0425)

Screening compound: C<sub>25</sub>H<sub>35</sub>N<sub>5</sub>O<sub>2</sub> (P636-0425)
Screening compound: C<sub>25</sub>H<sub>35</sub>N<sub>5</sub>O<sub>2</sub> (P636-0425) alternative view

Chemical Structure Depiction of ChemDiv screening compound
C25H35N5O2 (P636-0425)

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P636-0425

Molecular Formula

C25H35N5O2 (C25 H35 N5 O2)

Compound Name

N-[2-(azepan-1-yl)ethyl]-1-(1-benzyl-6-oxo-1,6-dihydropyridazin-4-yl)piperidine-4-carboxamide

IUPAC name

N-[2-(azepan-1-yl)ethyl]-1-(1-benzyl-6-oxo-16-dihydropyridazin-4-yl)piperidine-4-carboxamide

SMILES

O=C(C(CC1)CCN1C(C=NN1Cc2ccccc2)=CC1=O)NCCN1CCCCCC1

InChI

InChI=1S/C25H35N5O2/c31-24-18-23(19-27-30(24)20-21-8-4-3-5-9-21)29-15-10-22(11-16-29)25(32)26-12-17-28-13-6-1-2-7-14-28/h3-5,8-9,18-19,22H,1-2,6-7,10-17,20H2,(H,26,32)

InChI Key

PBKVRJBZQISVPL-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27608546

C25H35N5O2 (P636-0425) in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

Nonpeptide Peptidomimetics PPI Library (18997 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

SmartTM Library (51161 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Hemic and lymphatic
  • Cardiovascular
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • GPCR
  • Proteases
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics
  • Cyclic compounds

References: we are preparing a list of scientific research reports with C25H35N5O2 (P636-0425) chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C25H35N5O2 (P636-0425)?
Check Price and Availability of C25H35N5O2 (P636-0425), then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C25H35N5O2 (P636-0425) you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C25H35N5O2 (P636-0425)
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C25H35N5O2 (P636-0425)
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C25H35N5O2 (P636-0425) available by request